Semin Neurol 2000; 20(4): 447-454
DOI: 10.1055/s-2000-13177
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Alzheimer's Disease and Its Focal Variants

Joel H. Kramer, Bruce L. Miller
  • University of California, San Francisco Medical Center, San Francisco, California
Further Information

Publication History

Publication Date:
03 March 2004 (online)

ABSTRACT

Alzheimer's disease (AD) is the most common form of dementia in elderly individuals. Although the diagnosis of AD requires pathological confirmation, several common clinical features of AD have been identified. These include insidious onset, gradual progression, medial temporal atrophy, temporoparietal hypoperfusion, early and prominent deficits in episodic memory and mental tracking, and later deficits in semantic memory. These characteristic features of AD have enabled excellent in vivo diagnostic sensitivity. It has become increasingly clear, however, that AD is a heterogeneous disorder. The left and right cerebral hemispheres can be affected to varying degrees, and variability on the anterior-posterior axis has also been reported. AD can also present as a focal degenerative disease, and clinicians must be aware that there may be diagnostic overlap between AD, primary progressive aphasia, posterior cortical atrophy, corticobasal degeneration, and frontotemporal dementia.

REFERENCES

  • 1 Kolb B, Wishaw I. Fundamentals of Human Neuropsychology.  3rd ed. New York: Freeman; 1991
  • 2 Katzman R, Kawas C. The epidemiology of dementia and Alzheimer's disease. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer's Disease New York: Raven Press 1994: 104-122
  • 3 Weiner M F, Vega G, Risser R C. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease.  Biol Psychiatry . 1999;  45 633-638
  • 4 Slooter A J, Cruts M, Kalmijn S. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.  Arch Neurol . 1998;  55 964-968
  • 5 Saunders A M, Hulette O, Welsh-Bohmer K A. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.  Lancet . 1996;  348 90-93
  • 6 Craft S, Teri L, Edland S D. Accelerated decline in apolipoprotein E-epsilon 4 homozygotes with Alzheimer's disease.  Neurology . 1998;  51 149-153
  • 7 van Duijm M C, Hofman A, Kay D W. Risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies.  Int J Epidemiol . 1991;  20 4-12
  • 8 Davis D G, Schmitt F A, Wekstein D R, Markesbery W R. Alzheimer neuropathologic alterations in aged cognitively normal subjects.  J Neuropathol Exp Neurol . 1999;  58 376-388
  • 9 Mirra S S. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary.  Neurobiol Aging . 1997;  18(suppl 4) S91-S94
  • 10 Braak H, Braak E, Yilmazer D, de Vos A R, Jansen E N, Bohl J. Pattern of brain destruction in Parkinson's and Alzheimer's diseases.  J Neural Transm . 1996;  103 455-490
  • 11 Delacourte A, David J P, Sergeant N. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.  Neurology . 1999;  52 1158-1165
  • 12 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.  Neurology . 1984;  34 939-944
  • 13 Nagy Z, Esiri M M, Hindley N J. Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols.  Dement Geriatr Cogn Disord . 1998;  9 219-226
  • 14 Jobst K A, Barnetson L P, Shepstone B J. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. [corrected and republished article originally printed in Int Psychogeriatr 1997;9(suppl 1):191-222; discussion 247-252].  Int Psychogeriatr . 1998;  10 271-302
  • 15 DeCarli C, Kaye J A, Horwitz B, Rapoport S I. Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type.  Neurology . 1990;  40 872-883
  • 16 Sandor T, Jolesz F, Tieman J, Kikinis R, Jones K, Albert M. Comparative analysis of computed tomographic and magnetic resonance imaging scans in Alzheimer patients and controls.  Arch Neurol . 1992;  49 381-384
  • 17 Foundas A L, Eure K F, Seltzer B. Conventional MRI volumetric measures of parietal and insular cortex in Alzheimer's disease.  Prog Neuropsychopharmacol Biol Psychiatry . 1996;  20 1131-1144
  • 18 Smith C D, Malcein M, Meurer K, Schmitt F A, Markesbery W R, Pettigrew L C. MRI temporal lobe volume measures and neuropsychologic function in Alzheimer's disease.  J Neuroimaging . 1999;  9 2-9
  • 19 Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes.  Neurobiol Aging. 1995;  16 271-278 discussion, 278-discussion, 284
  • 20 Squire L R. Memory and Brain.  New York: Oxford University Press; 1987
  • 21 Mori E, Ikeda M, Hirono N, Kitagaki H, Imamura T, Shimomura T. Amygdalar volume and emotional memory in Alzheimer's disease.  Am J Psychiatry . 1999;  156 216-222
  • 22 Schuff N, Amend D L, Meyerhoff D J. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain.  Radiology . 1998;  207 91-102
  • 23 Juottonen K, Laakso M P, Partanen K, Soininen H. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease.  AJNR . 1999;  20 139-144
  • 24 Visser P J, Scheltens P, Verhey F R. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.  J Neurol . 1999;  246 477-485
  • 25 Zakzanis K K. Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer's type.  J Clin Exp Neuropsychol . 1998;  20 259-269
  • 26 Pantel J, Schroder J, Essig M. In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer's disease: an MRI-based study.  Dement Geriatr Cogn Disord . 1998;  9 309-316
  • 27 Schuff N, Amend D, Ezekiel F. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease: a proton MR spectroscopic imaging and MRI study.  Neurology . 1997;  49 1513-1521
  • 28 Haxby J V, Duara R, Grady C L, Cutler N R, Rapoport S I. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.  J Cereb Blood Flow Metab . 1985;  5 193-200
  • 29 Collette F, Van der Linden M, Salmon E. Executive dysfunction in Alzheimer's disease [published erratum appears in Cortex 1999;35:451].  Cortex . 1999;  35 57-72
  • 30 Jacobs D M, Sano M, Dooneief G, Marder K, Bell K L, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease.  Neurology . 1995;  45 957-962
  • 31 Folstein M F, Blysma F W. Noncognitive symptoms of Alzheimer's disease. In: Terry RD, Katzman R, eds. Alzheimer's Disease New York: Raven Press 1994: 27-40
  • 32 Martin A, Brouwers P, Lalonde F. Towards a behavioral typology of Alzheimer's patients.  J Clin Exp Neuropsychol . 1986;  8 594-610
  • 33 Fisher N J, Rourke B P, Bieliauskas L A, Giordani B, Berent S, Foster N L. Unmasking the heterogeneity of Alzheimer's disease: case studies of individuals from distinct neuropsychological subgroups.  J Clin Exp Neuropsychol . 1997;  19 713-754
  • 34 Friedland R P, Budinger T F, Koss E, Ober B A. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.  Neurosci Lett . 1985;  53 235-240
  • 35 Haxby J V, Grady C L, Koss E. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type.  Arch Neurol . 1990;  47 753-760
  • 36 Grady C L, Haxby J V, Schapiro M B. Subgroups in dementia of the Alzheimer type identified using positron emission tomography.  J Neuropsychiatry Clin Neurosci . 1990;  2 373-384
  • 37 Becker J T, Huff F J, Nebes R D, Holland A, Boller F. Neuropsychological function in Alzheimer's disease: pattern of impairment and rates of progression.  Arch Neurol . 1988;  45 263-268
  • 38 Mesulam M M. Slowly progressive aphasia without generalized dementia.  Ann Neurol . 1982;  11 592-598
  • 39 Westbury C, Bub D. Primary progressive aphasia: a review of 112 cases.  Brain Lang . 1997;  60 381-406
  • 40 Black S E. Focal cortical atrophy syndromes.  Brain Cogn . 1996;  31 188-229
  • 41 Greene J D, Miles K, Hodges J R. Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type.  J Neurol . 1996;  243 175-190
  • 42 Ross S J, Graham N, Stuart-Green L. Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease.  J Neurol Neurosurg Psychiatry . 1996;  61 388-395
  • 43 Benson D F, Davis R J, Snyder B D. Posterior cortical atrophy.  Arch Neurol . 1988;  45 789-793
  • 44 Victoroff J, Ross G W, Benson D F, Verity M A, Vinters H V. Posterior cortical atrophy: neuropathologic correlations.  Arch Neurol . 1994;  51 269-274
  • 45 Hof P R, Vogt B A, Bouras C, Morrison J H. Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways.  Vision Res . 1997;  27 3609-3625
  • 46 Hof P R, Archin N, Osmand A P. Posterior cortical atrophy in Alzheimer's disease: analysis of a new case and re-evaluation of a historical report.  Acta Neuropathol . 1993;  86 215-223
  • 47 Levine D N, Lee J M, Fisher C M. The visual variant of Alzheimer's disease: a clinicopathologic case study.  Neurology . 1993;  43 305-313
  • 48 Heilman K M, Rothi L J. Apraxia. In: Heilman KM, Valenstein E, eds. Clinical Neuropsychology 3rd ed. New York: Oxford University Press 1993: 141-163
  • 49 Beatty W W, Scott J G, Wilson D A, Prince J R, Williamson D J. Memory deficits in a demented patient with probable corticobasal degeneration.  J Geriatr Psychiatry Neurol . 1995;  8 132-136
  • 50 Kaida K, Takeda K, Nagata N, Kamakura K. Alzheimer's disease with asymmetric parietal lobe atrophy: a case report.  J Neurol Sci . 1998;  160 96-99
  • 51 Johnson J K, Head E, Kim R, Starr A, Cotman C W. Clinical and pathological evidence for a frontal variant of Alzheimer disease.  Arch Neurol . 1999;  56 1233-1239
  • 52 Neary D, Snowden J S, Gustafson L. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.  Neurology . 1998;  51 1546-1554
  • 53 Gregory C A, Serra-Mestres J, Hodges J R. Early diagnosis of the frontal variant of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests?.  Neuropsychiatry Neuropsychol Behav Neurol . 1999;  12 128-135
  • 54 Hodges J R, Patterson K, Ward R. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study.  Neuropsychology . 1999;  13 31-40
    >